BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23065027)

  • 21. Glutamine as a mediator of ammonia neurotoxicity: A critical appraisal.
    Albrecht J; Zielińska M; Norenberg MD
    Biochem Pharmacol; 2010 Nov; 80(9):1303-8. PubMed ID: 20654582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of glutamine synthetase activity by [13N]ammonia uptake in living rat brain.
    Momosaki S; Ito M; Tonomura M; Abe K
    Synapse; 2015 Jan; 69(1):26-32. PubMed ID: 25196365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preserved hypocapnic pial arteriolar constriction during hyperammonemia by glutamine synthetase inhibition.
    Hirata T; Kawaguchi T; Brusilow SW; Traystman RJ; Koehler RC
    Am J Physiol; 1999 Feb; 276(2):H456-63. PubMed ID: 9950845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Methionine sulfoximine, an inhibitor of glutamine synthetase, lowers brain glutamine and glutamate in a mouse model of ALS.
    Ghoddoussi F; Galloway MP; Jambekar A; Bame M; Needleman R; Brusilow WS
    J Neurol Sci; 2010 Mar; 290(1-2):41-7. PubMed ID: 20060132
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Current state of knowledge of hepatic encephalopathy (part I): newer treatment strategies for hyperammonemia in liver failure.
    Kristiansen RG
    Metab Brain Dis; 2016 Dec; 31(6):1357-1358. PubMed ID: 27651377
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alteration of striatal glutamate release after glutamine synthetase inhibition.
    Rothstein JD; Tabakoff B
    J Neurochem; 1984 Nov; 43(5):1438-46. PubMed ID: 6149260
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Multifactorial Effects on Different Types of Brain Cells Contribute to Ammonia Toxicity.
    Hertz L; Song D; Peng L; Chen Y
    Neurochem Res; 2017 Mar; 42(3):721-736. PubMed ID: 27286679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. DNA-Encoded Glutamine Synthetase Enzyme as Ammonia-Lowering Therapeutic for Hyperammonemia.
    Khoshnejad M; Dia Y; Patel A; Xu Z; Zhu X; Yun K; Wojtak K; Qureshi R; Humeau L; Muthumani K; Weiner DB
    Nucleic Acid Ther; 2020 Dec; 30(6):379-391. PubMed ID: 32907467
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Methionine sulfoximine, a glutamine synthetase inhibitor, attenuates increased extracellular potassium activity during acute hyperammonemia.
    Sugimoto H; Koehler RC; Wilson DA; Brusilow SW; Traystman RJ
    J Cereb Blood Flow Metab; 1997 Jan; 17(1):44-9. PubMed ID: 8978385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene Therapy for Treatment of Chronic Hyperammonemia in a Rat Model of Hepatic Encephalopathy.
    Espíritu-Ramírez P; Ortega-Balderas NY; Sevilla-Tapia L; Montiel-Martínez AG; Pastor-Flores AR; Palomares LA; Torres-Vega MA
    Ann Hepatol; 2018 Oct; 17(6):1026-1034. PubMed ID: 30600292
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Taurine treatment preserves brain and liver mitochondrial function in a rat model of fulminant hepatic failure and hyperammonemia.
    Jamshidzadeh A; Heidari R; Abasvali M; Zarei M; Ommati MM; Abdoli N; Khodaei F; Yeganeh Y; Jafari F; Zarei A; Latifpour Z; Mardani E; Azarpira N; Asadi B; Najibi A
    Biomed Pharmacother; 2017 Feb; 86():514-520. PubMed ID: 28024286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ornithine phenylacetate targets alterations in the expression and activity of glutamine synthase and glutaminase to reduce ammonia levels in bile duct ligated rats.
    Jover-Cobos M; Noiret L; Lee K; Sharma V; Habtesion A; Romero-Gomez M; Davies N; Jalan R
    J Hepatol; 2014 Mar; 60(3):545-53. PubMed ID: 24512823
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatic glutamine synthetase augmentation enhances ammonia detoxification.
    Soria LR; Nitzahn M; De Angelis A; Khoja S; Attanasio S; Annunziata P; Palmer DJ; Ng P; Lipshutz GS; Brunetti-Pierri N
    J Inherit Metab Dis; 2019 Nov; 42(6):1128-1135. PubMed ID: 30724386
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A zebrafish model of hyperammonemia.
    Feldman B; Tuchman M; Caldovic L
    Mol Genet Metab; 2014; 113(1-2):142-7. PubMed ID: 25069822
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of the convulsant methionine sulfoximine on striatal dopamine metabolism.
    Rothstein JD; Tabakoff B
    J Neurochem; 1982 Aug; 39(2):452-7. PubMed ID: 6123558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ammonia toxicity and tolerance in the brain of the African sharptooth catfish, Clarias gariepinus.
    Wee NL; Tng YY; Cheng HT; Lee SM; Chew SF; Ip YK
    Aquat Toxicol; 2007 May; 82(3):204-13. PubMed ID: 17383743
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hyperammonemia in gene-targeted mice lacking functional hepatic glutamine synthetase.
    Qvartskhava N; Lang PA; Görg B; Pozdeev VI; Ortiz MP; Lang KS; Bidmon HJ; Lang E; Leibrock CB; Herebian D; Bode JG; Lang F; Häussinger D
    Proc Natl Acad Sci U S A; 2015 Apr; 112(17):5521-6. PubMed ID: 25870278
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glutamine synthetase inhibition prevents cerebral oedema during hyperammonemia.
    Takahashi H; Koehler RC; Brusilow SW; Traystman RJ
    Acta Neurochir Suppl (Wien); 1990; 51():346-7. PubMed ID: 1982483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inhibition of glutamine synthetase in the central nucleus of the amygdala induces anhedonic behavior and recurrent seizures in a rat model of mesial temporal lobe epilepsy.
    Gruenbaum SE; Wang H; Zaveri HP; Tang AB; Lee TS; Eid T; Dhaher R
    Epilepsy Behav; 2015 Oct; 51():96-103. PubMed ID: 26262937
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acute ammonia toxicity and the protective effects of methionine sulfoximine on the swamp eel, Monopterus albus.
    Tng YY; Chew SF; Wee NL; Wong FK; Wong WP; Tok CY; Ip YK
    J Exp Zool A Ecol Genet Physiol; 2009 Nov; 311(9):676-88. PubMed ID: 19544359
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.